[1]宋春燕,王翠英.参芎葡萄糖联合放疗治疗局部晚期非小细胞肺癌50例临床观察[J].西部中医药,2013,26(01):89.
 SONG Chunyan,WANG Cuiying.Clinical Observation on ShenXiong Glucose Combined with Radiotherapy for 50 Cases of Local Non-small-cell Lung Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(01):89.
点击复制

参芎葡萄糖联合放疗治疗局部晚期非小细胞肺癌50例临床观察
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年01期
页码:
89
栏目:
报道·衷中参西
出版日期:
2013-01-15

文章信息/Info

Title:
Clinical Observation on ShenXiong Glucose Combined with Radiotherapy for 50 Cases of Local Non-small-cell Lung Cancer at Advanced Stage
文章编号:
1004-6852(2013)01-0089-02
作者:
宋春燕王翠英
衡水市第四人民医院肿瘤科,河北 衡水 053000
Author(s):
SONG Chunyan WANG Cuiying
Oncology in Hengshui Municipal the Fourth People忆s Hospital, Hengshui 053000, China
关键词:
非小细胞肺癌参芎葡萄糖放疗毒副反应
Keywords:
non-small-cell lung cancer ShenXiong glucose radiotherapy toxicity
分类号:
R734.2
文献标志码:
B
摘要:
目的:观察参芎葡萄糖联合放疗治疗局部晚期非小细胞肺癌的临床疗效。方法:将92例患者随机分为治疗组50例、对照组42例。2组均给予放疗治疗,治疗组同时给予参芎葡萄糖静脉滴注。观察2组患者治疗前后近期疗效、生存率及毒副反应。结果:治疗组近期疗效优于对照组(P<0.05),毒副反应小于对照组
(P<0.05)。患者生存率2组比较差异无统计学意义(P>0.05)。结论:参芎葡萄糖联合放疗治疗局部晚期非小细胞肺癌可提高疗效,减轻毒副反应。
Abstract:
Objective: To observe clinical effects of ShenXiong glucose and radiotherapy in the treatment for local non-small-cell lung cancer (NSCLC) at advanced stage. Method: All 92 patients were randomly divided into 50 cases in the treatment group and 42 cases in the control group. Both groups received radiotherapy, treatment group were given with intravenous dripping of ShenXiong glucose. Curative effects in the near future before and after treating, survival rate and toxicity of both groups were observed. Result: Curative effect in the near future of the treatment group was superior to that of control group (P< 0.05), toxicity was lighter than control group (P<0.05). Comparisons between both groups in survival rates showed difference without statistical meaning (P >0.05).Conclusion: ShenXiong glucose and radiotherapy in treating local NSCLC at advanced stage can improve curative
effects and relieve toxicity.

参考文献/References:

[1] 王树军.局部晚期非小细胞肺癌外科综合性治疗进展[J].临床肺科杂志,2010,15(1):67-69.
[2] 孙燕,石远凯.临床肿瘤内科手册[M].5 版.北京:人民卫生出版社,2009.
[3] 侯友贤.肿瘤放疗并发症防治[M].北京:人民军医出版社,2008:27-29.
[4] 朱莉莉,李玉梅,梁蕊,等.参芎葡萄糖注射液治疗特发性肺间质纤维化的疗效观察[J].临床肺科杂志,2011,16(10):1492-1493.

相似文献/References:

[1]席彩霞,杨国泉,苏安平,等.贞芪益气胶囊联合 GP 方案治疗晚期非小细胞肺癌的临床研究[J].西部中医药,2014,27(09):4.
[2]廖绛阳,张红△.血府逐瘀汤加味配合γ-刀治疗气虚血瘀证中晚期非小细胞肺癌30例[J].西部中医药,2015,28(10):98.
[3]焦富成.阿加曲班联合参芎葡萄糖治疗进展性脑梗死35例[J].西部中医药,2014,27(02):112.
 JIAO Fucheng.Argatroban and ShenXiong Glucose for 35 Cases of Progressive Cerebral Infarction[J].Western Journal of Traditional Chinese Medicine,2014,27(01):112.
[4]魏海东,王晓平,万毅新,等.康艾注射液联合NP方案治疗非小细胞肺癌50例疗效观察[J].西部中医药,2012,25(09):57.
 WEI Hai-dong,WANG Xiao-ping,WAN Yi-xin,et al.Kang′ai Injection and NP Therapy in the Treatment for 50 Cases of Non-Small-Cell Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(01):57.
[5]郭继龙,李斌,李亚玲,等.益气养阴汤联合化疗治疗气阴两虚型中晚期非小细胞肺癌30例[J].西部中医药,2017,30(08):84.
 GUO Jilong,LI Bin,LI Yaling,et al.Qi-tonifying Yin-nourishing Decoction Combined with Chemotherapy in Treating 30 Cases of Advanced Non Small-cell Lung Cancer of Dual Deficiency Pattern of Qi-Yin[J].Western Journal of Traditional Chinese Medicine,2017,30(01):84.
[6]朱小英.舒适化护理在非小细胞肺癌化疗患者中的应用效果评价[J].西部中医药,2019,32(08):133.
 ZHU Xiaoying.Effects Evaluation of Comfortable Nursing Applied to NSCLC Patients Undergoing Chemotherapy[J].Western Journal of Traditional Chinese Medicine,2019,32(01):133.
[7]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
 TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[8]刘爽,杨阳阳,魏巍.3-PR参与式健康教育在NSCLC患者护理中的应用[J].西部中医药,2022,35(02):137.[doi:10.12174/j.issn.2096-9600.2022.02.35]
 LIU Shuang,YANG Yangyang,WEI Wei.Application of 3-PR Participatory Health Education in the Care for NSCLC Patients[J].Western Journal of Traditional Chinese Medicine,2022,35(01):137.[doi:10.12174/j.issn.2096-9600.2022.02.35]
[9]王兆阳.年龄因素对非小细胞肺癌患者化疗耐受性的影响[J].西部中医药,2021,34(11):149.[doi:10.12174/j.issn.2096-9600.2021.11.34]
 WANG Zhaoyang.Effects of Age on Chemotherapy Tolerance in Patients with Non-small Cell Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2021,34(01):149.[doi:10.12174/j.issn.2096-9600.2021.11.34]
[10]徐克菲,罗保平,周用.参芪扶正注射液联合化疗治疗非小细胞肺癌系统评价/Meta分析文献质量评价[J].西部中医药,2021,34(09):70.[doi:10.12174/j.issn.2096-9600.2021.09.20]
 XU Kefei,LUO Baoping,ZHOU Yong.Literature Quality Evaluation of Meta Analysis/Systematic Evaluation of Shenqi Fuzheng Injection Combined with Chemotherapy in Treating Non-small Cell Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2021,34(01):70.[doi:10.12174/j.issn.2096-9600.2021.09.20]

备注/Memo

备注/Memo:
收稿日期:2012-09-02
作者简介:宋春燕(1980—),女,硕士学位,主治医师。研究方向:肿瘤疾病的中西医结合治疗。
更新日期/Last Update: 1900-01-01